| 000 | 01085 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512114744.0 | ||
| 264 | 0 | _c19740517 | |
| 008 | 197405s 0 0 eng d | ||
| 022 | _a0031-7012 | ||
| 024 | 7 |
_a10.1159/000136455 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuffman, D H | |
| 245 | 0 | 0 |
_aThe effect of spironolactone on antipyrine metabolism in man. _h[electronic resource] |
| 260 |
_bPharmacology _c1973 |
||
| 300 |
_a338-44 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipyrine _xmetabolism |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxylation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSpironolactone _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aShoeman, D W | |
| 700 | 1 | _aPentikäinen, P | |
| 700 | 1 | _aAzarnoff, D L | |
| 773 | 0 |
_tPharmacology _gvol. 10 _gno. 6 _gp. 338-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000136455 _zAvailable from publisher's website |
| 999 |
_c4597766 _d4597766 |
||